摘要: There are few problems more frustrating and depressing to oncologists and cancer patients alike than drug resistance. It comes in two varieties: intrinsic and acquired. Historically, the …
springer.com
proquest.com
sci-hub.se 参考文章(9)
J. Marx, CANCER RESEARCH: Why Some Leukemia Cells Resist STI-571 Science. ,vol. 292, pp. 2231a- 2233 ,(2001) , 10.1126/SCIENCE.292.5525.2231A
Gabriel Helmlinger, Fan Yuan, Marc Dellian, Rakesh K. Jain, Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nature Medicine. ,vol. 3, pp. 177- 182 ,(1997) , 10.1038/NM0297-177
Mercedes E Gorre, Mansoor Mohammed, Katharine Ellwood, Nicholas Hsu, Ron Paquette, P Nagesh Rao, Charles L Sawyers, Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification Science. ,vol. 293, pp. 876- 880 ,(2001) , 10.1126/SCIENCE.1062538
Brian J. Druker, Nicholas B. Lydon, Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia Journal of Clinical Investigation. ,vol. 105, pp. 3- 7 ,(2000) , 10.1172/JCI9083
C. Gambacorti-Passerini, Role of alpha1 Acid Glycoprotein in the In Vivo Resistance of Human BCR-ABL+ Leukemic Cells to the Abl Inhibitor STI571 Journal of the National Cancer Institute. ,vol. 92, pp. 1641- 1650 ,(2000) , 10.1093/JNCI/92.20.1641
Alicia Viloria-Petit, Janusz Rak, Serge Jothy, Daniel Hicklin, Robert S. Kerbel, Peter Bohlen, Jean Marc Schlaeppi, Tania Crombet, Acquired Resistance to the Antitumor Effect of Epidermal Growth Factor Receptor-blocking Antibodies in Vivo A Role for Altered Tumor Angiogenesis Cancer Research. ,vol. 61, pp. 5090- 5101 ,(2001)
Brian J. Druker, Charles L. Sawyers, Hagop Kantarjian, Debra J. Resta, Sofia Fernandes Reese, John M. Ford, Renaud Capdeville, Moshe Talpaz, Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome The New England Journal of Medicine. ,vol. 344, pp. 1038- 1042 ,(2001) , 10.1056/NEJM200104053441402
Heikki Joensuu, Peter J. Roberts, Maarit Sarlomo-Rikala, Leif C. Andersson, Pekka Tervahartiala, David Tuveson, Sandra L. Silberman, Renaud Capdeville, Sasa Dimitrijevic, Brian Druker, George D. Demetri, Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor The New England Journal of Medicine. ,vol. 344, pp. 1052- 1056 ,(2001) , 10.1056/NEJM200104053441404
Brian J. Druker, Moshe Talpaz, Debra J. Resta, Bin Peng, Elisabeth Buchdunger, John M. Ford, Nicholas B. Lydon, Hagop Kantarjian, Renaud Capdeville, Sayuri Ohno-Jones, Charles L. Sawyers, Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia The New England Journal of Medicine. ,vol. 344, pp. 1031- 1037 ,(2001) , 10.1056/NEJM200104053441401